nicorandil has been researched along with Torsade de Pointes in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirayama, A; Kasamaki, Y; Kofune, M; Kunimoto, S; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I | 1 |
Aizawa, Y; Chinushi, M; Furushima, H; Inuzuka, H; Ojima, K; Shibata, A | 1 |
Aizawa, Y; Arita, M; Nakayama, T; Uchiyama, H; Yamaura, M | 1 |
Fukuda, H; Hirabayashi, Y; Igarashi, T; Inoue, S; Mitsuhata, H; Saitoh, K; Shimizu, R; Suzuki, H | 1 |
Ito, H; Nakamura, W; Okumura, T; Segawa, K; Takeda, H; Watanabe, O; Yoshimoto, N | 1 |
Antzelevitch, C; Shimizu, W | 1 |
6 other study(ies) available for nicorandil and Torsade de Pointes
Article | Year |
---|---|
Effect of the ATP-sensitive K⁺ channel opener nicorandil in a canine model of proarrhythmia.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Dose-Response Relationship, Drug; Electrocardiography; KATP Channels; Long QT Syndrome; Nicorandil; Pyrimidinones; Torsades de Pointes; Ventricular Premature Complexes | 2011 |
Nicorandil suppresses a hump on the monophasic action potential and torsade de pointes in a patient with idiopathic long QT syndrome.
Topics: Action Potentials; Aged; Anti-Arrhythmia Agents; Female; Humans; Long QT Syndrome; Niacinamide; Nicorandil; Torsades de Pointes | 1995 |
Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome. Investigator Group for K-Channel Openers and Arrhythmias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrocardiography; Electrocardiography, Ambulatory; Female; Humans; Infusions, Intravenous; Long QT Syndrome; Male; Middle Aged; Niacinamide; Nicorandil; Potassium Channels; Torsades de Pointes | 1998 |
Nicorandil successfully abolished intraoperative torsade de pointes.
Topics: Aged; Electrocardiography; Female; Humans; Intraoperative Complications; Niacinamide; Nicorandil; Torsades de Pointes; Vasodilator Agents | 1998 |
Nicorandil, a potassium channel opener, abolished torsades de pointes in a patient with complete atrioventricular block.
Topics: Aged; Anesthetics, Local; Anti-Arrhythmia Agents; Bradycardia; Cardiotonic Agents; Electrocardiography; Female; Heart Block; Humans; Isoproterenol; Lidocaine; Nicorandil; Potassium Channels; Torsades de Pointes; Ventricular Fibrillation | 1999 |
Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Chromans; Cnidarian Venoms; Dogs; Electrocardiography; Electrophysiology; Heart; Isoproterenol; Long QT Syndrome; Nicorandil; Potassium Channels; Reaction Time; Sotalol; Sulfonamides; Torsades de Pointes | 2000 |